Peter A. Crooks
University of Arkansas for Medical Sciences
H-index: 66
North America-United States
Top articles of Peter A. Crooks
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats | Biochemical Pharmacology | Cassie M Chandler Justin R Nickell A George Wilson John P Culver Peter A Crooks | 2024/4/3 |
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof | 2023/4/27 | ||
Novel tdzd analogs as agents that delay, prevent, or reverse age-associated diseases and as anti-cancer and antileukemic agents | 2023/4/27 | ||
DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic … | 2023/3/30 | ||
Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan | Pharmaceuticals | Samuel Kakraba Srinivas Ayyadevara Nirjal Mainali Meenakshisundaram Balasubramaniam Suresh Bowroju | 2023/10/20 |
Cellulose Based Anti-Viral Anti-Microbial Spray Coating | 2023/6/8 | ||
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats | Frontiers in Pharmacology | Venumadhav Janganati Paloma Salazar Brian J Parks Gregory S Gorman Paul L Prather | 2023/5/9 |
Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells | Frontiers in Toxicology | Francesca V LoBianco Kimberly J Krager Erica Johnson Christopher O Godwin Antino R Allen | 2022/12/14 |
Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse | 2022/10/6 | ||
Indole molecules and use thereof in the inhibition of dna polymerases | 2022/3/31 | ||
Compact dual-band antenna with high gain and simple geometry for 5G cellular communication operating at 28 GHz and 44 GHz | Musa Hussain Abdullah Mazher Eamin Chaudary Bilal Hussain Mohammad Alibakhshikenari | 2021/8/28 | |
Characterizing the access of cholinergic antagonists to efferent synapses in the inner ear | Frontiers in Neuroscience | Choongheon Lee Anjali K Sinha Kenneth Henry Anqi W Walbaum Peter A Crooks | 2021/12/14 |
Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone | Toxicology Reports | Zaineb AF Albayati Narsimha R Penthala Shobanbabu Bommagani Ginell R Post Mark S Smeltzer | 2021/1/1 |
Dehydroleucodine derivatives and uses thereof | 2021/7/13 | ||
Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD) | European journal of medicinal chemistry | Narsimha R Penthala Meenakshisundaram Balasubramaniam Soma Shekar Dachavaram Earl J Morris Poornima Bhat-Nakshatri | 2021/11/15 |
Abstract PR-003: Radiosensitization by targeting the NPM1/RAD51 axis | Clinical Cancer Research | Michael L Freeman Geri Traver Konjeti R Sekhar Peter A Crooks | 2021/4/15 |
Selected antihypertensive agents and their fixed-dose combinations effectively ameliorate trastuzumab-mediated cardiac dysfunction in rats | Nigerian Journal of Physiological Sciences | Peter Anthony Crooks A A Adeneye Olufunke Esan Olorundare Temidayo Olutayo Omobowale Akinyele Olubiyi Akinsola Phillip Manma Kolo | 2021/6/30 |
Biobanked glioblastoma patient-derived organoids as a precision medicine model to study inhibition of invasion | International Journal of Molecular Sciences | Emilie Darrigues Edward H Zhao Annick De Loose Madison P Lee Michael J Borrelli | 2021/10/3 |
Therapeutic potentials of selected antihypertensive agents and their fixed-dose combinations against trastuzumab-mediated cardiotoxicity | Frontiers in Pharmacology | Olufunke Esan Olorundare Adejuwon Adewale Adeneye Akinyele Olubiyi Akinsola Abayomi Mayowa Ajayi Olalekan Ayodele Agede | 2021/3/4 |
Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer’s disease | Bioorganic & medicinal chemistry | Suresh K Bowroju Narsimha R Penthala Naga Rajiv Lakkaniga Meenakshisundaram Balasubramaniam Srinivas Ayyadevara | 2021/9/1 |